Irinotecan Discontinuation and Reintroduction for Advanced Colorectal Cancer

Sponsor
Gachon University Gil Medical Center
Study ID
NCT00320320
Phase
PHASE2
Status
Terminated

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of this study is to evaluate the feasibility and efficacy of first-line FOLFIRI discontinuation after initial 8 cycles and reintroduction after progression.

Key Dates

Start date
Apr 30, 2005
Status verified
Nov 2008
Primary completion
Apr 30, 2007
Completion
Apr 30, 2007

Study Design

Enrollment
72 participants
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Primary Outcome Measure

Response rate after FOLFIRI reintroduction

Related Studies